ZS Pharma, Inc. (Nasdaq: ZSPH), today confirmed that it has participated in preliminary discussions with Actelion ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Mergers and Acquisitions

ZS Pharma's (ZSPH) Price Target Raised to $83 at BMOSeptember 11, 2015 8:22 AM ZS Pharma's (ZSPH) Price Target Raised to $110 at William Blair September 11, 2015 8:21 AM ZS Pharma (ZSPH) to Resume Trading at 5:50 PMSeptember 10, 2015 5:36 PM Actelion Confirms Discussions with ZS Pharma (ZSPH)September 10, 2015 5:17 PM ZS Pharma (ZSPH) halted with news pendingSeptember 10, 2015 4:32 PM Relypsa (RLYP) Gains in Sympathy with ZS Pharma (ZSPH)September 10, 2015 2:39 PM ZS Pharma (ZSPH) Halted on LUDPSeptember 10, 2015 2:25 PM Actelion Said to Make Approach for ZS Pharma (ZSPH)September 10, 2015 2:24 PM UPDATE: ZS Pharma (ZSPH) Shares Surge; Conference Cancellation ConfirmedSeptember 10, 2015 10:14 AM